Vulcan Value Partners reported positive absolute performance in all strategies in the third quarter of 2025. The Large Cap Composite returned 4.6%, Small Cap Composite 4.1%, Focus Composite 3.7%, Focus Plus Composite 3.7%, and All-Cap Composite 5.5% net of fees. Top five holdings for the year are available in the investor letter.

Medpace Holdings, Inc. (NASDAQ:MEDP) gained 50.00% in the last 52 weeks, with a one-month return of 2.47%. As of October 15, 2025, the stock closed at $514.32 per share, holding a market capitalization of $14.449 billion. Vulcan Value Partners highlighted Medpace Holdings, Inc. (NASDAQ:MEDP) as a contributor to strong performance.

Medpace Holdings, Inc. (NASDAQ:MEDP) reported revenue of $603.3 million in the second quarter of 2025, up 14.2% year-over-year. The company showcased accelerated growth due to a better biotech funding environment and increased outlook for revenue and earnings. Medpace Holdings, Inc. (NASDAQ:MEDP) is not in the 30 Most Popular Stocks Among Hedge Funds list.

Headwaters Capital Management shares positive views on Medpace Holdings, Inc. (NASDAQ:MEDP). For more investor letters from hedge funds and leading investors, visit the hedge fund investor letters Q3 2025 page. Check out the latest articles on the best and worst Dow stocks and 10 unstoppable stocks that could double your money.

Read more at Yahoo Finance: Should You be Excited about Medpace Holdings’ (MEDP) Prospects?